Patent Assignment
Reel/Frame 067235/0081
Assignment of Assignor's Interest
Recorded: 2024-04-26
Pages: 9
Assignee
HORIZON THERAPEUTICS USA, INC.
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Properties
(2)
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (Triple)
Application:
62/798,782 →
PCT:
PCT/US2020/015956 ↗
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (Triple)
Application:
62/903,562 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 31, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC
Reel/Frame 061805/0076 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 061805 Frame 0076. Assignor(S) Hereby Confirms the Assignment.
Dec 1, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 062073/0930 →